Menu Close

When did Evista go generic?

When did Evista go generic?

The FDA has approved raloxifene (generic Evista) as of March 2014. Brand name Evista was first approved in 1997.

How long has Evista been on the market?

Evista was one of a spate of US Food and Drug Administration approvals at the end of last year (Marketletter December 15, 1997), and its launch is expected to expand the osteoporosis market as a whole.

When was Evista approved by FDA?

Approval Date: 9/30/1999.

Is there a generic for Evista?

Generic name: Raloxifene Evista is the trade name for Raloxifene. In some cases, health care professionals may use the trade name Evista when referring to the generic drug name Raloxifene. Drug type: Evista is a hormone therapy. This medication is classified as a Selective Estrogen Receptor Modulator (SERM).

Who is the manufacturer of EVISTA?

Today, Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has approved its osteoporosis drug EVISTA(R) (raloxifene HCl) for a new use to reduce the risk of invasive breast cancer in two populations: postmenopausal women with osteoporosis and postmenopausal women at high risk …

What tier drug is EVISTA?

Medicare prescription drug plans typically list raloxifene on Tier 2 of their formulary.

Is Evista still on the market?

Therapy was discontinued due to an adverse reaction in 11.4% of 581 Evista-treated women and 12.2% of 584 placebo-treated women.

Where can I buy Evista online?

RXConnected makes buying Evista and other prescription and non-prescription medications simple and affordable. All of our medications are sent directly to you saving you hassle and time. RXConnected can help you to save 90% on the cost of your drugs. Order online or call us now.

What is the black box warning for raloxifene?

Black box warnings were added to the label of raloxifene in 2007 warning of increased risk of death due to stroke for postmenopausal women with documented coronary heart disease or at increased risk for major coronary events, as well as increased risk for deep vein thrombosis and pulmonary embolism.

What tier drug is Evista?

Who manufactures Evista?

Evista (raloxifene) – Lilly Medical.

What is raloxifene hydrochloride used for?

Raloxifene is used to prevent and treat osteoporosis (condition in which the bones become thin and weak and break easily) in postmenopausal (women who have experienced a change of life; end of menstrual periods) women.

What are the side effects of Evista after 4 years?

The safety profile of EVISTA after four years of treatment was similar to that of EVISTA following three years of therapy. Additional adverse events (>2% and more common with EVISTA than with placebo) included hot flashes, leg cramps, swelling, flu-like symptoms, joint pain and sweating.

How is Evista used in the treatment of osteoporosis?

EVISTA is approved by the U.S. Foodand Drug Administration(FDA) for the treatment and prevention of osteoporosis in postmenopausal women.  EVISTA is also indicated for the reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis. There are Important Limitations of Use for breast cancer risk reduction:

How is Evista evaluated for breast cancer risk reduction?

Use of EVISTA was evaluated by changes in vertebral fracture risk reduction, bone mineral density (BMD), markers of bone turnover, iliac crest bone biopsies, and invasive breast cancer risk reduction:

How does Evista work as an estrogen antagonist?

EVISTA is an estrogen agonist/antagonist, commonly referred to as a selective estrogen receptor modulator (SERM), which appears to act like estrogen in bone and to block the effects of estrogen in some tissues.